Access this article Similar content being viewed by others Data Availability Not applicable
Yes, but there was a catch
Beginning July 1, 2026, the Medicare GLP-1 Bridge Program may allow eligible Medicare Part D patients to access certain obesity-indicated GLP-1 medications, including Foundayo, Wegovy, and certain Zepbound formulations, for no more than $50 per month through December 31, 2027
Readers are strongly advised to consult with a qualified healthcare professional before making any decisions regarding their health, including the use of GLP-1 receptor agonists or any other medication discussed herein
Significant Scientific Interest Researchers worldwide continue to investigate Retatrutide due to its unique receptor profile and extensive research potential
The GLP-1 Nutrition Support Kit costs approximately $309.20 per month when enrolled in the Premier+ autoship program